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Aim: Endothelin-1 (ET-1) and angiotensin II (Ang II) are multifunctional peptide hormones 
that regulate the function of the cardiovascular and renal systems. Both hormones increase 
the intracellular production of inositol-1,4,5-trisphosphate (IP3) by activating their 
membrane-bound receptors. We  have previously demonstrated that IP3-mediated 
sarcoplasmic reticulum (SR) Ca2+ release results in mitochondrial Ca2+ uptake and activation 
of ATP production. In this study, we tested the hypothesis that intact SR/mitochondria 
microdomains are required for metabolic IP3-mediated SR/mitochondrial feedback in 
ventricular myocytes.
Methods: As a model for disrupted mitochondrial/SR microdomains, cardio-specific 
tamoxifen-inducible mitofusin 2 (Mfn2) knock out (KO) mice were used. Mitochondrial 
Ca2+ uptake, membrane potential, redox state, and ATP generation were monitored in 
freshly isolated ventricular myocytes from Mfn2 KO mice and their control wild-type (WT) 
littermates.
Results: Stimulation of ET-1 receptors in healthy control myocytes increases mitochondrial 
Ca2+ uptake, maintains mitochondrial membrane potential and redox balance leading to 
the enhanced ATP generation. Mitochondrial Ca2+ uptake upon ET-1 stimulation was 
significantly higher in interfibrillar (IFM) and perinuclear (PNM) mitochondria compared to 
subsarcolemmal mitochondria (SSM) in WT myocytes. Mfn2 KO completely abolished 
mitochondrial Ca2+ uptake in IFM and PNM mitochondria but not in SSM. However, 
mitochondrial Ca2+ uptake induced by beta-adrenergic receptors activation with 
isoproterenol (ISO) was highest in SSM, intermediate in IFM, and smallest in PNM regions. 
Furthermore, Mfn2 KO did not affect ISO-induced mitochondrial Ca2+ uptake in SSM and 
IFM mitochondria; however, enhanced mitochondrial Ca2+ uptake in PNM. In contrast to 
ET-1, ISO induced a decrease in ATP levels in WT myocytes. Mfn2 KO abolished ATP 
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INTRODUCTION
Heart failure (HF) is one of the most common chronic conditions 
associated with aging. Despite advances in HF treatment, it 
has a poor prognosis with a steady increase in mortality and 
incidence in the aging population (Lloyd-Jones et  al., 2002; 
Nieminen et  al., 2006). Current treatments of HF rely almost 
entirely on altering the neurohormonal milieu, using agents 
such as angiotensin converting enzyme (ACE) inhibitors, 
angiotensin receptor blockers, and beta-adrenergic blockers to 
improve cardiac function and reduce mortality. Importantly, 
there are no proven interventions that are directly targeted 
toward maintaining cardiac function and myocyte survival. The 
pathogenesis of HF is the result of numerous changes in the 
whole organism with striking subcellular modifications especially 
at the level of mitochondria: the number of cristae of the 
inner mitochondrial membrane (IMM) is reduced, and due 
to subcellular changes, the contact sites of mitochondria and 
the sarcoplasmic reticulum (SR) are significantly diminished. 
Depending on the type of cardiomyopathy, both decreased 
respiratory chain activity due to impaired mitochondrial 
complexes I  and III (Ventura-Clapier et  al., 2011; Thai et  al., 
2018) or increased respiratory chain activity due to increased 
expression of uncoupling proteins (Sebastiani et  al., 2007), 
could lead to increased proton leak and decline in ATP 
generation. The heart has the highest energy demand by weight 
of any organ in the body, and its function fails within minutes 
if mitochondrial ATP production is interrupted. Therefore, 
addressing mitochondrial dysfunction and decrease in 
mitochondrial ATP generation may represent an effective 
treatment for HF directly targeting the key features in 
its pathogenesis.
An increase in mitochondrial calcium (Ca2+) concentration 
([Ca2+]m) is thought to be  one of the major factors responsible 
for the activation of Ca2+-dependent dehydrogenases eventually 
leading to stimulation of the oxidative phosphorylation and 
ATP generation (Balaban, 2009). Recent studies utilizing 
mitochondrial Ca2+ uniporter (MCU) knockout (KO) mice (Pan 
et al., 2013; Kwong et al., 2015) questioned this accepted dogma 
since mitochondrial bioenergetics and ATP generation were 
not significantly compromised in those animals. Only when 
cardiac myocytes were challenged with the beta-adrenergic 
agonist isoproterenol (ISO), MCU KO myocytes were not able 
to match ATP production and respiratory rates in response 
to an increased work load (Kwong et  al., 2015). These data 
indicate that although MCU is considered the major pathway 
for mitochondrial Ca2+ uptake in cardiac myocytes, other 
pathways located in the inner mitochondrial membrane (IMM) 
may compensate for the lack of MCU and play a role in the 
regulation of mitochondrial Ca2+ uptake and ATP generation. 
The mitochondrial ryanodine receptor (mRyR1) was proposed 
to be  an alternative mitochondrial Ca2+ uptake pathway in 
cardiac myocytes (Beutner et  al., 2005; Jakob et  al., 2014) 
while the physiological function and relevance of this pathway 
are still controversial. Recently, we  were able to demonstrate 
that Ca2+ released from the sarcoplasmic reticulum (SR) via 
the inositol 1,4,5-trisphosphate receptor (IP3R) is taken up into 
the mitochondrial matrix via the mRyR1 (Seidlmayer et  al., 
2016), where it activates ATP production. This IP3-mediated 
mitochondria/SR feedback is essential for the adaptation of 
mitochondrial metabolism to chronic stress as induced by 
endothelin-1 (ET-1) or angiotensin (Ang II).
Ca2+ release from intracellular stores is the essential signal 
generated by electrical activation in cardiomyocytes, which is 
required to initiate cell contraction in the process known as 
excitation-contraction coupling (ECC). To release Ca2+ from 
the SR, cardiac myocytes express two different Ca2+ release 
channels: (1) the ryanodine receptor type 2 (RyR2), which is 
Ca2+ sensitive and releases Ca2+ from the SR during ECC upon 
Ca2+ entrance through the voltage-gated L-type Ca2+ channels 
and (2) the inositol 1,4,5-trisphosphate (IP3) receptor (IP3R), 
which releases Ca2+ after binding of IP3 independently from 
generation upon ET-1 stimulation but increased ATP levels upon ISO application with 
highest levels observed in PNM regions.
Conclusion: When the physical link between SR and mitochondria by Mfn2 was disrupted, 
the SR/mitochondrial metabolic feedback mechanism was impaired resulting in the inability 
of the IP3-mediated SR Ca2+ release to induce ATP production in ventricular myocytes 
from Mfn2 KO mice. Furthermore, we  revealed the difference in Mfn2-mediated 
SR-mitochondrial communication depending on mitochondrial location and type of 
communication (IP3R-mRyR1 vs. ryanodine receptor type 2-mitochondrial calcium uniporter).
Keywords: mitofusin 2, IP3 signaling, SR/mitochondria metabolic feedback, mitochondrial mRyR1, ATP generation, 
endothelin-1, Mfn2 KO mice
Abbreviations: ΔΨm, Mitochondrial membrane potential; ACE, Angiotensin 
converting enzyme; Ang II, Angiotensin II; Ca2+, Calcium; [Ca2+]i, Cytosolic 
calcium concentration; [Ca2+]m, Mitochondrial calcium concentration; CHF, 
Congestive heart failure; ECC, Excitation-contraction coupling; ET-1, Endothelin-1; 
FAD, Flavin adenine dinucleotide; IFM, Interfibrillar mitochondria; IMM, Inner 
mitochondrial membrane; IP3, Inositol 1,4,5-trisphosphate; IP3R, Inositol 
1,4,5-trisphosphate receptor; ISO, Isoproterenol; KO, Knockout; MCU, Mitochondrial 
Ca2+ uniporter; Mfn2, Mitofusin 2; mRyR1, Mitochondrial ryanodine receptor 
type 1; NADH, Reduced nicotinamide adenine dinucleotide; PNM, Perinuclear 
mitochondria; RyR1, Ryanodine receptor type 1; SR, Sarcoplasmic reticulum; 
SSM, Subsarcolemmal mitochondria; VDAC1, Voltage-dependent anion channel 1; 
VDAC2, Voltage-dependent anion channel 2; WT, Wild-type.
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ECC. IP3 is cleaved from phosphatidylinositol-4,5-bisphosphate 
(PIP2) by phospholipase C when hormones like ET-1 or Ang 
II bind to their membrane bound G-protein-coupled receptors. 
Although IP3Rs are less abundant in ventricular myocytes 
compared to RyR2s, their activation results in measurable 
Ca2+ increase during diastole and systole creating areas with 
highly, localized concentrations of Ca2+, known as microdomains. 
These microdomains are typically formed at the junction between 
the SR and mitochondria resulting in elevation of the cytosolic 
Ca2+ from 0.1 to ~30  μM, which leads to the activation of 
mitochondrial Ca2+ uptake (Szalai et  al., 2000; Dedkova and 
Blatter, 2008; Dedkova et  al., 2013; Dorn and Maack, 2013).
Cardiac myocytes display a highly organized structure: 
mitochondria, SR, and the contractile apparatus are tightly 
packed. Mitochondria occupy about 40% of the myocytes 
volume (Zhou et  al., 1998). Based on the proximity of 
mitochondria to the Ca2+ release sites, mitochondria are 
divided into subsarcolemmal (SSM), interfibrillar (IFM) and 
perinuclear mitochondria (PNM). All three subgroups differ 
in enzymatic activity (Palmer et  al., 1977; Matlib et  al., 1978; 
McMillin-Wood et al., 1980) and shape (Fawcett and McNutt, 
1969; Lukyanenko et  al., 2009). SSM are located underneath 
the sarcolemma, PNM are located around nuclei, while IFM 
are localized between the myofilaments where they are in 
close contact to the Ca2+ release sites in the junctional SR 
(Chikando et  al., 2011).
In addition to this spatial relationship, mitochondria and 
the SR are linked physically by electron dense structures called 
tethers (Csordás et al., 2006). In mammalian cells, these tethers 
are formed by protein complexes containing IP3R (Szabadkai 
et  al., 2006) and mitofusins, mainly containing mitofusin 1 
(Mfn1) and mitofusin 2 (Mfn2). Despite both molecules are 
homologues, Mfn1 mainly mediates mitochondrial fusion (Cipolat 
et al., 2004), whereas Mfn2 plays an important role in mitophagy 
(Schrepfer and Scorrano, 2016), controls the shape of the 
endoplasmic reticulum, and tethers mitochondria and the SR 
mechanically to each other to ensure the proper communication 
between the two organelles (de Brito and Scorrano, 2008). 
This latter function of Mfn2 has been challenged by Filadi 
et  al. (2015) who suggested that Mfn2-tethers actually keep 
mitochondria far away from the SR to prevent mitochondrial 
Ca2+ overload. In a series of experiments, they demonstrated 
that KO of Mfn2 in cultured cells improved the communication 
between the two organelles, suggesting that Mfn2 is a negative 
regulator of tethering. Critical re-evaluation of Mfn2 function, 
however, confirmed the original discovery from Scorrano’s group 
that Mfn2 tethers serve to mediate the proper transfer of Ca2+ 
from the SR to mitochondria (Naon et al., 2016). In non-excitable 
cells, it has been shown that IP3Rs-mediated Ca2+ tunneling 
to mitochondria is an essential modulator of cell bioenergetics 
and ATP production (Cárdenas et  al., 2010). However, the 
role of Mfn2 in IP3Rs-mediated Ca2+ tunneling to mitochondria 
and energetics in cardiac myocytes has not been evaluated yet.
In the present study, we  aimed to examine the role of 
Mfn2 in the IP3Rs-mediated SR/mitochondria metabolic feedback 
mechanism described above. The hypothesis is that an intact 
linkage of SR and mitochondria is required for basal metabolic 
control of the IP3-mediated Ca2+ release in cardiac myocytes. 
Our hypothesis was tested using the cardiac-specific, tamoxifen-
induced knockout of Mfn2 (Mfn2 KO). We  found that when 
the physical link between SR and mitochondria by Mfn2 was 
disrupted, the SR/mitochondrial metabolic feedback mechanism 
was impaired resulting in the inability of the IP3-mediated SR 
Ca2+ release to induce ATP production in ventricular myocytes 
from Mfn2 KO mice. We  further revealed the difference in 
Mfn-2 mediated SR-mitochondrial communication depending 
on mitochondrial location and type of receptor (IP3R vs. 
Ryanodine receptor), which can explain the existing controversy 
in the field.
MATERIALS AND METHODS
Animal Model
Mfn2loxp/loxp/cre (Mfn2 KO) mice were obtained from the laboratory 
of Prof. Gerald W. Dorn, II in St. Louis, Missouri, USA. For 
induction of Cre-mediated deletion of Mfn2, mice were fed 
20  mg tamoxifen/kg body weight/day for 7  days. Littermates 
of Mfn2 KO mice (heterozygous for Mfn2) were used as control 
animals and designated as wild-type (WT) group. All 
experimental procedures were in accordance with the Guide 
for the Care and Use of Laboratory Animals published by the 
US National Institutes of Health (8th Edition, 2011) and approved 
by the University of Würzburg Institutional Animal Care and 
Use Committee.
Cell Isolation
Adult left ventricular myocytes were isolated from 10- to 
16-week-old Mfn2 KO mice and their healthy littermates. Mice 
were anesthetized with isoflurane and sacrificed by cervical 
dislocation. The excised heart was mounted to a Langendorff 
perfusion system and retrogradely perfused with Ca2+-free 
washing solution followed by enzyme solution containing 
Liberase TH (Research Grade, Roche, Basel, Switzerland) as 
described previously (Seidlmayer et al., 2016). Isolated myocytes 
were kept in Tyrode solution containing 1  mM Ca2+.
Immunoblot Analysis
Left ventricular tissue was homogenized in ice-cold lysis buffer 
(50  mM Tris pH 7.5, 1  mM EDTA, 1  mM EGTA, 10% 
glycerol, 1% triton X-100, 50 mM NaF, 5 mM Na4P2O7, 1 mM 
Na3VO4, 1 mM DTT, protease inhibitor cocktail), and protein 
content was determined using the BCA assay. About 30  μg 
of protein was separated by 10% SDS-PAGE and transferred 
onto 0.2  μm PVDF membrane and blocked with 5% nonfat 
dry milk in phosphate-buffered saline (PBS) containing 0.1% 
Tween-20 (PBS-T). Blocked membranes were exposed to 
primary antibodies toward total Mfn2 (Abcam mouse 
monoclonal anti-Mfn2, ab56889, 1:2000 dilution) and GAPDH 
(Cell Signaling antibodies, 36,835, 1:2000 dilution). Sheep 
anti-mouse immunoglobulin G (IgG) antibodies (GE Healthcare 
NA9310V) in 1:4000 dilution were used as secondary antibodies. 
Protein bands were visualized by enhanced chemiluminescence 
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(GE Healthcare Life Sciences). Mfn2 bands were normalized 
to GAPDH bands using the software ScanPack 3.0.
Real-Time PCR
After extraction of total RNA using a RNA fibrous tissue mini 
kit (Qiagen, Venlo, Netherlands), cDNA was synthesized from 
1  μg of RNA using the iScript™ cDNA synthesis kit (Bio-Rad, 
Hercules, CA). Quantitative reverse transcription-polymerase 
chain reaction (qRT-PCR) was performed with commercial 
and customized TaqMan probes (Life Technologies™, Waltham, 
Massachusetts, USA). Target gene mRNA levels were normalized 
to glyceraldehyde 3-phosphate dehydrogenase (GAPDH), which 
served as housekeeping gene for comparison.
Confocal Microscopy
Laser scanning confocal microscopy (Leica SP5 and a Zeiss 
LSM 780) was used to follow the changes in cytosolic ([Ca2+]i) 
and mitochondrial ([Ca2+]m) Ca2+ concentration, mitochondrial 
membrane potential (ΔΨm), reactive oxygen species (ROS) 
generation, and mitochondrial ATP generation using specific 
fluorescent indicators. All fluorescent signals were recorded in 
electrically stimulated (0.5  Hz) single cardiac myocytes. For 
measurements, the myocytes were plated on laminin-covered 
coverslips and incubated in Tyrode solution containing 1  mM 
Ca2+ at room temperature. The fluorescence image was recorded 
every 10  s. Fluorescence levels were corrected for background 
fluorescence and normalized to untreated control (F0) (F/F0).
[Ca2+]m Measurements
Changes in mitochondrial Ca2+ concentration ([Ca2+]m) were 
measured in intact cells using the Ca2+-sensitive fluorescent 
probe X-Rhod-1/AM (molecular probes, λex  =  543  nm and 
λem  =  552–617  nm). Myocytes were loaded with the dye for 
30  min at 37°C. This loading procedure favors mitochondrial 
localization of X-Rhod-1. To quench the remaining cytosolic 
fluorescence, the myocytes were incubated in 1  mM CoCl2-
containing Tyrode during washout period as published before 
(Seidlmayer et  al., 2015, 2016).
Analysis of Mitochondrial Subfractions
For the analysis of [Ca2+]m levels in SSM, a longitudinal region 
of interest (ROI) was placed directly underneath the sarcolemma 
and for IFM in the center of the cell excluding the nuclei. 
Changes in [Ca2+]m levels in perinuclear regions (PNM) were 
detected in the ROIs located from each side of the nucleus. 
Fluorescence changes over time were analyzed.
ATP Measurement
ATP concentration was measured indirectly via the free magnesium 
(Mg2+) concentration using the fluorescent probe 
mag-fluo-4  AM  (Invitrogen) and directly using a commercially 
available ATP luciferase assay (Invitrogen, Waltham, Massachusetts, 
USA, #A22066) (Seidlmayer et  al., 2016). This indirect method 
is based on the fact that ATP forms complexes with Mg2+. 
Since free [Mg2+]i is kept constant within a rather narrow range, 
ATP hydrolysis leads to concomitant increase in free [Mg2+]i 
as measured with fluorescent Mg2+ indicators such as mag-fluo-4. 
Therefore, an increase in mag-fluo-4 fluorescence indicates a 
decrease in ATP concentration. For indirect ATP measurements, 
myocytes were loaded with 10  μM mag-fluo-4 (λex  =  488  nm 
and λem  =  565–605  nm) for 30  min at 37°C. All data are 
expressed as an inverted ratio R  =  1 − F/F0.
Mitochondrial Membrane Potential 
Measurements
Mitochondrial membrane potential (ΔΨm) was measured in 
intact myocytes using the potentiometric probe 
tetramethylrhodamine methyl ester (TMRM) (λex  =  543  nm 
and λem = 565–605 nm) (Dedkova and Blatter, 2012; Seidlmayer 
et  al., 2015, 2016). The myocytes were loaded with 10  nM 
TMRM for 15  min at 37°C. 10  nM TMRM was present in 
all solutions during the experiments. In the end of each 
experiment, 5  μM carbonyl cyanide p-(trifluoromethoxy)
phenylhydrazone (FCCP) and 1  μM oligomycin were added 
to calibrate the signal. All data were background corrected.
Redox Measurements
Isolated adult ventricular myocytes from WT mice were field-
stimulated at 37°C with a stimulation rate of 0.5  Hz and 
superfused with normal Tyrode’s (NT) solution containing (in 
mM) NaCl 130, KCl 5, MgCl2 1, CaCl2 1, Na-HEPES 10, 
glucose 10, sodium pyruvate 2, and ascorbic acid 0.3, pH 7.4. 
After 120 s, cardiac myocytes were superfused with NT solution 
containing either 10  nM endothelin or 500  nM isoproterenol. 
We  monitored changes in redox status of cardiomyocytes by 
measuring autofluorescence of two endogenous tissue 
fluorophores: reduced form of nicotinamide adenine dinucleotide 
(NADH, transfers electrons to molecular oxygen) and flavin 
adenine dinucleotide (FAD+, which is an electron acceptor) 
(Dedkova and Blatter, 2012). NADH has fluorescence excitation 
and emission maxima at 350 and 460  nm, respectively. FAD+ 
has fluorescence excitation and emission maxima at 450 and 
535  nm, respectively. During this protocol, NADH 
(λex  =  340  nm; λem  =  450  nm) and FAD+ (λex  =  480  nm; 
λem = 520 nm) autofluorescence were recorded using an IonOptix 
set-up as described previously in (Kohlhaas et  al., 2017). 
Calibration was performed with FCCP (5 μmol/L) and cyanide 
(4  mmol/L). “Redox ratio,” which represents approximation of 
the reduction-to-oxidation status of the mitochondrial matrix 
space, was calculated by dividing the fluorescence intensity of 
NADH to the fluorescence intensity of FAD+.
Statistics
The data are normalized to untreated control and background 
corrected. All data are presented as mean  ± standard error 
of the mean for the indicated number (n) of experiments. 
For comparisons of multiple groups in Figure 1, ANOVA 
was used. A significant overall F-test multi-group comparison 
was done via Tukey’s test (including correction for multiple 
testing) for treatment vs. control. For comparisons of only 
two groups, Student’s t-test was used. Data were considered 
significant at p  <  0.05.
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RESULTS
Expression of Mfn2 Was Effectively 
Abolished by Tamoxifen Treatment in  
Mfn2 KO Mice
To test our hypothesis that disturbed SR/mitochondrial contacts 
due to Mfn2 knockout affect the SR/mitochondrial metabolic 
feedback mechanism, experiments were performed in tamoxifen-
inducible cardiac-specific Mfn2 knockout (Mfn2 KO) mice 
(Chen et  al., 2011). To verify that Mfn2 protein was effectively 
reduced by tamoxifen, Western blot analysis was performed 
in heart tissue lysates collected 1 and 7  days after beginning 
of tamoxifen treatment. As shown in representative Western 
blot images in Figure 1A, Mfn2 expression was significantly 
reduced after 1 day of tamoxifen treatment and almost completely 
eliminated (90% decrease compared to WT myocytes) after 
7 days of tamoxifen (Figure 1B). These results were confirmed 
by quantifying RNA levels of Mfn2 using real-time PCR. As 
shown in Figure 1C, the relative RNA in Mfn2 KO was 
0.09  ±  0.07 (n  =  3) compared to 1.0  ±  0.37 (n  =  4), in WT 
mice. To verify that knockout of Mfn2 has no effect on the 
proteins involved in cardiac ECC, we  tested the expression 
levels of RyR types 1 and 2, MCU, and voltage-dependent 
anion channel 1 (VDAC1) and 2 (VDAC2) by real-time PCR. 
As demonstrated in Figure 1D, expression levels of both RyR 
types 1 and 2, MCU, VDAC1, and VDAC2 were not altered 
by Mfn2 knockout.
Ca2+ Released via the IP3R Cannot  
Be Taken Up Into Mitochondria in  
Mfn2 KO mice
We have recently demonstrated (Seidlmayer et  al., 2016) that 
Ca2+ released from the SR upon IP3R activation is taken up 
into the mitochondrial matrix in WT cardiomyocytes. 10 nM 
ET-1 induced a significant increase in mitochondrial Ca2+, 
which could be  abolished by cell treatment with 3  μM of 
the IP3R antagonist 2-APB (Seidlmayer et  al., 2016). Since 
IP3-mediated global cytosolic Ca2+ changes are very small, 
experiments were designed to test the importance of the 
subcellular contacts between SR and mitochondria in Ca2+ 
tunneling directly from SR to mitochondria in Mfn2 KO 
mice in which the physical tethering of SR and mitochondria 
is disrupted. Consistent with our previous reports (Seidlmayer 
et  al., 2016), addition of 10  nM ET-1 to electrically field-
stimulated (0.5 Hz) ventricular myocytes induced a significant 
increase in mitochondrial Ca2+ uptake in WT myocytes 
(+35  ±  6%, n  =  7, Figures 2A,B, solid green trace). This 
ET-1-induced mitochondrial Ca2+ uptake was significantly 
blunted in Mfn2 KO myocytes (+17 ± 4%, n = 9) (Figures 2A,B, 
dashed green trace) confirming the importance of Mfn2  in 
ET-1 mediated Ca2+ transfer to mitochondria. Furthermore, 
we  confirmed that blocking mitochondrial Ca2+ uptake with 
the mRyR1 inhibitor dantrolene (1 μM), led to a corresponding 
increase in systolic Ca2+ level in the cytosol (Supplementary 
Figure S1). This indicates that when mitochondrial Ca2+ 
uptake via mRyR1 is not possible, Ca2+ released from SR is 
leaking out into cytosol. This Ca2+ leak from the SR in cytosol 
could contribute to pro-arrhythmic events described before 
(Proven et  al., 2006).
Control time recordings performed in untreated electrically 
field-stimulated (0.5  Hz) myocytes from WT (solid black 
trace, −1  ±  4%, n  =  6) and Mfn2 KO mice (dashed black 
trace, +3 ± 5%, n = 4) confirmed that there was no measurable 
increase in mitochondrial Ca2+ levels in the absence of ET-1 
stimulation (Figure 2B), confirming that the observed increase 
in mitochondrial Ca2+ was due to ET-1 activation of 
IP3 receptors.
A
D
B C
FIGURE 1 | Expression of Mfn2 was effectively abolished by 7 days of tamoxifen treatment in Mfn2 KO mice. (A) Original Western blots of Mfn2 and GAPDH in WT 
and Mfn2 KO mice exposed to tamoxifen for 0, 1, and 7 days. (B) Mfn2 normalized to GAPDH showing a significant decrease of Mfn2 in tamoxifen-treated mice. (C) 
Fold change expression normalized to GAPDH of Mfn2 after 7 days of tamoxifen treatment compared to untreated WT measured by real-time PCR. (D) Expression 
level of RyR1, RyR2, MCU, and VDAC1 and VDAC 2 in WT and Mfn2 KO mice measured by real-time PCR. *p £ 0.05 compared to WT, **p £ 0.01 compared to WT.
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Mfn2 KO Does Not Block Global  
ISO-Induced Mitochondrial Ca2+ Uptake
We have previously shown that when cytosolic Ca2+ was 
increased by the non-specific beta-adrenergic receptor agonist 
isoproterenol (ISO) in WT myocytes, which induces a global 
increase in cytosolic Ca2+ concentration, only a small increase 
in mitochondrial Ca2+ uptake was observed (Seidlmayer et al., 
2016). In this study, we  performed experiments in 
cardiomyocytes from Mfn2 KO mice, and their control 
littermates (WT) to examine whether intact Mfn-2-mediated 
contact sites are required for ISO-induced changes in [Ca2+]m. 
As shown in Figure 2A, we  found that mitochondrial Ca2+ 
increase induced by ISO (solid blue line) in electrically field-
stimulated (0.5  Hz) ventricular myocytes was significantly 
smaller (+20  ±  2%, n  =  7) compared to the ET-1-induced 
response (solid green line). Furthermore, in contrast to the 
data obtained with ET-1, Mfn2 KO had no effect on average 
ISO-induced mitochondrial Ca2+ uptake (+19  ±  4%, n  =  7, 
dashed blue line) (Figures 2A,B), indicating that intact spatial 
arrangement of SR and mitochondria was not critical for 
ISO-induced mitochondrial Ca2+ uptake.
Interfibrillar and Perinuclear Mitochondria 
Take Up More Ca2+ Following IP3-Mediated 
SR Ca2+ Release Compared to 
Subsarcolemmal Mitochondria
Since mitochondrial morphology and function vary between 
different mitochondrial subpopulations in the cell (Fawcett and 
McNutt, 1969; Palmer et al., 1977; Matlib et al., 1978; McMillin-
Wood et  al., 1980; Lukyanenko et  al., 2009), we  tested the 
importance of physical tethering of SR and mitochondria in 
different mitochondrial regions. As we  mentioned before, 
subsarcolemmal mitochondria (SSM) exist below the cell 
membrane, interfibrillar mitochondria (IFM) reside in rows 
A
B
FIGURE 2 | In Mfn2 KO mice Ca2+ released via the IP3R cannot be taken up into mitochondria. (A) The representative confocal traces recorded from adult 
ventricular myocytes loaded with the Ca2+-sensitive fluorescent dye X-Rhod-1 upon electrical field stimulation (FS, 0.5 Hz) and subsequent exposure to 10 nM ET-1 
(WT: solid green, Mfn2 KO: dashed green) or 500 nM ISO (WT: solid blue, Mfn2 KO: dashed blue), respectively. Changes in fluorescence reflect changes in 
mitochondrial Ca2+. (B) Mean values of the mitochondrial Ca2+ levels change during 20 min of observation. ET-1 increased mitochondrial Ca2+ concentration ([Ca2+]m) 
by +35 ± 6% (n = 7) in healthy WT myocytes, whereas ISO-induced elevation of [Ca2+]m was significantly smaller (+20 ± 2%, n = 7). In Mfn2 KO myocytes, the 
mitochondrial Ca2+ uptake induced by ET-1 was significantly smaller compared to WT myocytes (ET-1: +17 ± 4%, n = 9). However, the effect of ISO on 
mitochondrial Ca2+ uptake was not altered by Mfn2 KO (ISO: +19 ± 4%, n = 7). No significant changes in [Ca2+]m were observed in untreated WT (solid black) and 
Mfn2 KO (dashed black) myocytes during 20 min of observation. *p < 0.05 compared to untreated WT, **p £ 0.05 compared to untreated WT, #p £ 0.05 compared 
to WT treated with ET-1.
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between the myofibrils, and perinuclear mitochondria (PNM) 
are located around the nuclei. Electron microscopy studies 
revealed that the SR/mitochondrial cleft is only 10–25  nm 
(Chen et al., 2012). Since, due to their intracellular localization, 
the interorganellar contact differs between the different 
mitochondrial subpopulations, we  analyzed differences in IP3-
mediated mitochondrial Ca2+ uptake in these mitochondrial 
subfractions. For the analysis of [Ca2+]m levels in SSM, a 
longitudinal region of interest (ROI) was placed directly 
underneath the sarcolemma. For [Ca2+]m levels in IFM, ROIs 
were placed in the center of the cell excluding the nuclei. 
Changes in [Ca2+]m levels in perinuclear regions (PNM) were 
detected in the ROIs located from each side of the nucleus. 
As shown in Figure 3, subsarcolemmal mitochondria of WT 
myocytes take up significantly less Ca2+ than interfibrillar and 
perinuclear mitochondria following ET-1 stimulation (IFM: 
+47  ±  8% after 20  min, n  =  6; PNM: +47  ±  6% after 20  min, 
n  =  6 vs. SSM: +30  ±  8% after 20  min, n  =  6). In Mfn2 KO 
mice, mitochondrial Ca2+ uptake was significantly inhibited in 
IFM (+24  ±  4%, n  =  6, p  <  0.05 compared to WT) and PNM 
(+19  ±  4%, n  =  6, p  <  0.05) mitochondria following ET-1 
stimulation. There was no difference in [Ca2+]m levels upon 
ET-1 treatment in Mfn2 KO mitochondria from SSM regions 
(+20  ±  2%, n  =  8, p  =  0.23) (Figure 3). These data indicate 
that disruption of the SR-mitochondrial tethering in specific 
regions abolishes the differences in mitochondrial Ca2+ uptake 
induced by IP3-mediated Ca2+ release from SR in 
ventricular myocytes.
Interestingly, the effect of ISO on [Ca2+]m levels in the three 
mitochondrial subgroups was different from ET-1. The 
highest mitochondrial Ca2+ uptake was detected in 
subsarcolemmal mitochondria (+44 ± 12% after 20 min, n = 7), 
which gradually declined in IFM (+20  ±  9% after 20  min, 
n  =  7) and was the smallest in perinuclear (+11  ±  9% after 
20  min, n  =  7) mitochondria. Furthermore, while Mfn-2 KO 
had no effect on ISO-induced [Ca2+]m levels in SSM and IFM 
mitochondrial regions (Figures 3E,F), mitochondrial Ca2+ uptake 
was actually increased in perinuclear mitochondria (Figure 3G) 
in cardiomyocytes from Mfn2 KO animals.
These data suggest that tethering between SR and mitochondria 
is heterogeneous within ventricular myocytes to support the 
privileged SR-mitochondrial communication between IP3 
receptors and mRyR1. When this communication was lost in 
Mfn-2 KO mice, perinuclear mitochondria were able to pick 
more Ca2+ upon ISO stimulation.
IP3-Mediated Increase in Mitochondrial 
Membrane Potential Was  
Dependent on Mfn2
The Ca2+ taken up by mitochondria following ET-1 stimulation 
is activating mitochondrial oxidative phosphorylation, which 
results in a significant increase in ATP levels (Seidlmayer et al., 
2016). Here, we measured changes in mitochondrial membrane 
potential (ΔΨm) following ET-1 stimulation using the 
potentiometric probe TMRM in cardiac myocytes from WT 
and Mfn2 KO mice (Figure 4A). In WT myocytes, ET-1 
induced a significant hyperpolarization over 20 min (+37 ± 3%, 
n  =  13, p  <  0.01 compared to untreated controls), whereas 
in Mfn-2 KO ΔΨm decreased upon exposure to ET-1 (−11 ± 6%, 
n = 4, p < 0.01 compared to WT + ET-1) myocytes, indicating 
the importance of intact SR-mitochondrial contacts for 
mitochondrial ΔΨm maintenance.
To test if basal ΔΨm was different in WT and Mfn2 KO 
myocytes, we  measured TMRM fluorescence at the beginning 
of the experiment before cell treatment with ET-1. No significant 
difference in basal ΔΨm was detected (Figure 4B), suggesting 
that there is no difference in basal respiratory activity in WT 
and Mfn2 KO mice.
In support of these data, we  also found that while both 
ET-1 and ISO induced a decrease in reduced NADH 
(Figure  4C), changes in both reduced NADH and oxidized 
FAD+ levels (Figure 4D) were less pronounced upon ET-1 
stimulation resulting in minimal net redox ratio NADH/FAD+ 
changes (Figures 4E,F) normalized to untreated conditions 
whereas, in cells treated with ISO, the ratio declined significantly. 
Altogether, these data indicate that ET-1 maintains 
mitochondrial membrane potential and respiratory 
chain activity.
IP3-Mediated ATP Production Following 
ET-1 Stimulation Is Impaired in  
Mfn2 KO Mice
Next, we  monitored changes in [ATP]i indirectly using the 
[Mg2+]-sensitive dye mag-fluo-4  in WT and Mfn-2 KO cardiac 
myocytes treated with either 10  nM ET-1 or 100  nM ISO. 
This method takes advantage of the fact that ATP is a major 
Mg2+ buffer, such that an increase in [ATP]i level reduces free 
[Mg2+]i (Dedkova and Blatter, 2012). Therefore, increased ATP 
production causes mag-fluo-4 fluorescence to decline. In Figure 
5, the mag-fluo-4 signal was inverted so that an increase in 
the signal reflects an increase in [ATP]i. Similar to previous 
experiments, cardiac myocytes were electrically stimulated at 
the frequency of 0.5  Hz to maintain Ca2+ fluxes during ECC, 
and then ET-1 (10  nM) and ISO (500  nM) were applied to 
activate the correspondent receptors. As shown in Figure 5A, 
ET-1 but not ISO induced an increase in ATP generation in 
WT ventricular myocytes, which was abolished in Mfn2 KO 
myocytes emphasizing the importance of Mfn2 in Ca2+ transfer 
to mitochondria to mediate ATP production. As summarized 
in Figure 5B, ET-1 induced a significant increase in ATP 
levels over 20  min (+19.18  ±  3.7%, n  =  6), whereas in Mfn2 
KO myocytes the effect of ET-1 on ATP generation was 
completely abolished (+0.74  ±  1.5%, n  =  5). To the contrary, 
ISO-treatment caused a significant decrease in ATP levels in 
WT (−8.7 ± 1.2%, n = 4, p < 0.01), while a significant increase 
in ATP (+13.1  ±  3%, n  =  7, p  <  0.01) was observed in Mfn-2 
KO myocytes upon ISO stimulation.
We further analyzed the effect of ET-1 and ISO on ATP 
content in mitochondrial subgroups as we did for mitochondrial 
Ca2+ uptake. The results are summarized in Figure 5C. As 
expected, in Mfn2 KO myocytes, ET-1 was not able to induce 
a significant increase in ATP levels in all subgroups. 
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However, there was no significant difference in ET-1-induced 
ATP increase between IFM, SSM, and PNM in myocytes from 
WT or Mfn2 KO mice.
A decrease in ATP levels upon ISO exposure was more 
pronounced in IFM and SSM mitochondrial subgroups but 
remained unchanged in PNM (Figure 5C). In agreement, with 
A
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FIGURE 3 | IFM and PNM take up more Ca2+ than SSM following IP3-mediated SR Ca2+ release. (A) Original confocal image of an adult murine ventricular myocyte 
loaded with X-Rhod-1. Shown in white are regions of interest (ROIs) placed over SSM, IFM, and PNM for the analysis of Ca2+ changes in different mitochondrial 
regions. (B) Mean values for mitochondrial Ca2+ changes measured as changes in X-Rhod-1 fluorescence in SSM normalized to untreated controls (black: WT 
myocytes+ET-1; red: Mfn2 KO myocytes + ET-1). (C) Mean values for mitochondrial Ca2+ changes measured as changes in X-Rhod-1 fluorescence in IFM 
normalized to untreated controls (black: WT myocytes+ET-1; red: Mfn2 KO myocytes + ET-1). (D) Mean values for mitochondrial Ca2+ changes measured as 
changes in X-Rhod-1 fluorescence in PNM normalized to untreated controls (black: WT myocytes+ET-1; red: Mfn2 KO myocytes + ET-1). (E) Mean values for 
mitochondrial Ca2+ changes measured as changes in X-Rhod-1 fluorescence in SSM normalized to untreated controls (black: WT myocytes+ISO; red: Mfn2 KO 
myocytes + ISO). (F) Mean values for mitochondrial Ca2+ changes measured as changes in X-Rhod-1 fluorescence in IFM normalized to untreated controls (black: 
WT myocytes+ISO; red: Mfn2 KO myocytes + ISO). (G) Mean values for mitochondrial Ca2+ changes measured as changes in X-Rhod-1 fluorescence in PNM 
normalized to untreated controls (black: WT myocytes+ISO; red: Mfn2 KO myocytes + ISO). *p £ 0.05 compared to WT ET-1 or ISO vs. Mfn2 KO, **p £ 0.001 
compared to WT ET-1 or ISO vs. Mfn2 KO.
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the data presented in Figure 5B, ISO addition to Mfn2 KO 
myocytes increased ATP levels in all groups significantly 
compared to the corresponding groups in WT myocytes. 
Furthermore, PNM in Mfn 2 KO myocytes, which took more 
Ca2+ into the mitochondria, also increased ATP levels significantly 
higher than IFM and SSM from Mfn2 KO myocytes.
DISCUSSION
In this study, we  examined the role of SR-mitochondrial 
tethering by Mfn2  in activation of mitochondrial Ca2+ uptake 
and metabolism using mice with a cardiac-specific deletion 
of Mfn2 (Figure 1). We  tested the hypothesis that physical 
linkage of SR and mitochondria via Mfn2 is essential for 
IP3R-mediated signal transduction to mitochondria to maintain 
ATP levels in cardiac myocytes under physiological conditions 
(i.e., normal levels of IP3R expression and circulating ET-1). In 
our previous study (Seidlmayer et  al., 2016), we  found that the 
stimulation of cardiac myocytes with IP3R agonists induced 
mitochondrial Ca2+ uptake via mRyR1 and increased ATP content. 
In contrast, under basal conditions, beta-adrenergic stimulation 
with ISO was not able to induce measurable ATP production. 
Since the global changes in cytosolic Ca2+ concentration produced 
by IP3-mediated SR Ca2+ release are very small compared to 
RyR-mediated Ca2+ changes, here, we  examined the significance 
of intact SR-mitochondrial tethering by Mfn2 for IP3-mediated 
stimulation of mitochondrial Ca2+ uptake and ATP generation.
We found that the ability of ET-1 to induce a significant IP3-
dependent mitochondrial Ca2+ uptake was lost in myocytes from 
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FIGURE 4 | IP3R stimulation with ET-1 increases mitochondrial membrane potential in WT myocytes but not in Mfn2 KO myocytes. (A) Normalized mean values of 
TMRM fluorescence changes in WT (black line) and Mfn2 KO (red line) cardiac myocytes after exposure to 10 nM ET-1 for 20 min. TMRM signal was normalized to 
the level measured in untreated WT and Mfn2 KO myocytes. (B) Mean values of basal TMRM fluorescence in untreated myocytes from WT (black) and Mfn2 KO 
(red) mice. (C) Mean values of NADH in % of reduced NADH following ISO (red) and ET-1 (blue) treatment as well as untreated control (black) over 20 min. (D) Mean 
values of FAD+ in % of oxidized FAD+ following ISO (red) and ET-1 (blue) treatment as well as untreated control (black) over 20 min. (E) The ratio of NADH/FADH 
following the treatment with ET-1 (blue) and ISO (red). For comparison, untreated control is shown in black. (F) The normalized ratio of NADH/FADH following 
treatment with ET-1 (blue) and ISO (red) is shown. Black is the untreated control with electrical field stimulation at frequency 0.5 Hz. (A) *p £ 0.05 compared to 
untreated control, **p £ 0.001 compared to untreated control, #p £ 0.05 compared to WT treated with ET-1, ##p £ 0.001 compared to WT treated with ET-1. (C–F) 
#p £ 0.05, ##p £ 0.01, ###p £ 0.001; black – ISO vs. ctrl, gray – ET-1 vs. ctrl.
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Mfn2 KO mice (Figure 2). Interestingly, when myocytes from 
Mfn2 KO mice were stimulated with the beta-adrenergic receptor 
agonist ISO, mitochondrial Ca2+ uptake was not affected in SSM 
and IFM but significantly increased in PNM regions. When the 
influence of beta-adrenergic and IP3R stimulation on ATP content 
was examined (Figure 5), ET-1 did not induce an increase in 
ATP in myocytes from Mfn2 KO mice, indicating the importance 
of physical tethering of mitochondria and the SR for metabolic 
control by IP3 under physiological conditions. To the contrary, 
in Mfn2 KO myocytes, ISO significantly increased ATP content 
under conditions of electrical field stimulation, whereas in WT 
myocytes ISO led to a decrease in mitochondrial ATP content. 
The latter finding agrees with previous studies showing that sudden 
increase in work load causes a decrease in mitochondrial NADH 
(and presumably ATP levels), which recovered slowly over the 
time in a Ca2+-dependent manner (Brandes and Bers, 1997). 
Furthermore, another study demonstrated that beta-adrenergic 
stimulation with ISO induced only a transient MCU-dependent 
increase in oxygen consumption, suggesting that MCU only plays 
a role in acute matching of the mitochondrial energy output 
with increase in cardiac metabolic demand (Kwong et  al., 2015). 
However, over the time, oxygen consumption was not different 
between WT and MCU KO cardiac myocytes, indicating that 
another mitochondrial Ca2+ influx pathway contributes to the 
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FIGURE 5 | ATP production following IP3-mediated SR Ca2+ release is impaired in Mfn2 KO mice. (A) Original confocal traces of ATP levels recorded in WT 
myocytes stimulated with 10 nM ET-1 (black) or 500 nM ISO (blue) and Mfn2 KO cardiac myocytes stimulated with ET-1 (red) or ISO (green), respectively. Mg2+-
sensitive fluorescent dye mag-fluo-4 was used to monitor ATP levels inside cardiac myocytes. As free Mg2+ and ATP form complexes, increase in ATP concentration 
reduces free Mg2+ and thus mag-fluo-4 fluorescence. Traces are inverted for better understanding and presented as 1-F/F0. (B) Mean values of the experiment 
described in (A) in %. *p £ 0.05 compared to untreated WT; **p £ 0.01 compared to untreated WT; #p £ 0.05 compared to WT treated with ET-1 or ISO, 
respectively; ##p £ 0.01 compared to WT treated with ET-1 or ISO, respectively. (C–H) Subgroup analysis of subsarcolemmal (SSM, C,D), interfibrillar (IFM, E,F), 
and perinuclear (PNM, G,H) mitochondria in myocytes from WT (black) and Mfn2 KO (red) mice loaded with mag-fluo-4 as described in (A). The myocytes were 
treated with either ET-1 (left) or ISO (right). *p £ 0.05 compared to WT, **p £ 0.01 compared to WT.
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sustained energy generation in cardiac myocytes. Our data 
demonstrate that IP3R-mRyR1-mediated mitochondrial Ca2+ uptake 
contributes to the sustained ATP generation (Figure  6) and that 
this Ca2+ transfer from SR is regulated by Mfn2 under physiological 
conditions. When this regulation is lost in Mfn2 KO mice, IP3-
mediated Ca2+ release is not capable to stimulate ATP generation 
anymore, as observed in pathological conditions. Altogether, our 
data suggest that Mfn2 can provide a fine tuning to regulate 
Ca2+-dependent energy production under physiological conditions 
upon ET-1 stimulation, but when Mfn2-mediated tethering is 
disrupted, mitochondria can adapt to respond to global Ca2+ 
elevation induced by ISO with increase in ATP generation.
The disruption of Mfn2-mediated intact ER-mitochondrial 
contacts exists in conditions of heart failure induced by transverse 
aortic constriction (TAC), which is associated with a decreased 
excitability and force generation in cardiac myocytes (Goh 
et  al., 2016). ET-1 levels are typically increased in chronic 
stress as in the setting of congestive heart failure (CHF) (Wei 
et  al., 1994) along with increased myocardial expression of 
ETA receptors (Picard et  al., 1998; Pieske et  al., 1999). To 
determine if this increase in the ET-1 axis is pathologic, a 
mouse model was developed to conditionally overexpress ET-1 in 
the myocardium that led to nearly 10-fold increase in ET-1 
concentration in the heart, without any significant increase in 
circulating ET-1 levels (Yang et  al., 2004). Mice with elevated 
cardiac ET-1 expression presented with severe heart inflammation, 
hypertrophy leading to dilated cardiomyopathy, CHF, and death 
within 5  weeks of induction. However, a whole body ET-1 
KO (ET-1−/−) homozygous mice developed by disrupting exon 
2 of the ET-1 gene were neonatally lethal (Kurihara et  al., 
1994). ET-1−/− mice delivered by caesarean section at day 18.5 
postcoitum, all displayed significant craniofacial and cardiac 
abnormalities, highlighting the critical role of ET-1  in the 
development (Kurihara et  al., 1994, 1995b). Moreover, ET-1−/− 
mice had reduced neonatal weight, impaired thyroid and thymus 
development (Kurihara et  al., 1995a), and reduced cardiac 
sympathetic innervation (Ieda et  al., 2004). Mice heterozygous 
for ET-1 deletion, ET-1+/−, appeared normal, were fertile, and 
had reduced lung and plasma ET-1 concentration; however, 
they had elevated systolic, diastolic, and mean arterial blood 
pressure (Kurihara et  al., 1994). These observations suggest 
that while 10-fold elevation in ET-1 levels in cardiac myocytes 
is clearly pathological, basal levels of ET-1 are required for 
maintaining normal physiological function in cardiac myocytes.
FIGURE 6 | Summary of the proposed metabolic IP3-mediated SR/mitochondrial signaling pathway in the presence (upper panel) or absence (lower panel) of intact 
Mfn2-tethers. IP3-mediated mitochondrial Ca2+ uptake in WT myocytes (upper panel), which is followed by an increase in ATP generation. When the physical contact 
of mitochondria and the SR is disturbed by knockout of Mfn2 (lower panel), Ca2+ released from the SR by IP3 cannot be taken up into mitochondria anymore leading 
to the decrease in ATP level. Yellow circles: Ca2+, yellow arrow: Ca2+ movement, green arrow: IP3 movement.
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Indeed, myocardial ET-1 depicts beneficial effects depending 
on the physiological situation. In the myocardium, ET-1 prevents 
excessive apoptosis after cardiac overload induced by aortic 
banding (Zhao et al., 2006). Signaling of the anti-apoptotic effects 
of ET-1 involves calcineurin, the mitochondrial function, and 
the classical MEK1/2-ERK1/2 and PI3 kinase pathways (Iwai-
Kanai and Hasegawa, 2004). It has been reported that ET-1 
prevents the early phase of doxorubicin-induced cytotoxicity via 
the upregulation of the antioxidant manganese superoxide dismutase 
through the ETA receptor in cultured cardiomyocytes (Suzuki 
and Miyauchi, 2001). Preconditioning infusion of ET-1 can reduce 
infarct size in rats subjected to ischemia-reperfusion (Gourine 
et  al., 2005). The transgenic expression of ET-1  in mice lacking 
a functional gene for eNOS restores diastolic function presumably 
through modulation of oxidative stress and a change of metabolic 
substrate from fatty acid oxidation toward enhanced glycolysis 
(Vignon-Zellweger et  al., 2011). In line with this, the enhanced 
glycolysis in the failing heart, which is a beneficial compensatory 
mechanism, is accompanied by a hypoxia-inducible factor-1α-
dependent elevation of ET-1 expression (Kakinuma et  al., 2001).
Our study indicates that stimulation of ET-1 receptors in 
healthy control myocytes leads to mitochondrial Ca2+ uptake, 
maintains mitochondrial membrane potential, and activates 
ATP generation. Furthermore, we determined that intact Mfn2 
tethers were required to mediate Ca2+ uptake into mitochondria 
and stimulate ATP production. The significance of a physical 
linkage of SR and mitochondria in cardiac myocytes is still 
debated. Our data add new aspects to this discussion revealing 
the importance of Mfn2 tethers in IP3-mediated SR/mitochondrial 
metabolic feedback in ventricular myocytes. As shown by our 
group before (Seidlmayer et  al., 2016), Ca2+ released from the 
SR via the IP3R is taken up into mitochondria where it increases 
ATP content. Here, we  were able to demonstrate that this 
metabolic feedback is severely disturbed in Mfn2-deficient mice. 
When cardiac myocytes from these mice were stimulated with 
the IP3R agonist ET-1, no mitochondrial Ca2+ uptake could 
be  detected. In agreement with this finding, IP3-mediated SR 
Ca2+ release in Mfn2-deficient myocytes was not able to increase 
cellular ATP content. These results clearly show that intact 
tethering of SR and mitochondria via Mfn2 is crucial for the 
channeling of intracellular Ca2+ signals from IP3R to mRyR1 
located in mitochondria. In support of this, data presented in 
Supplementary Figure S1 demonstrate that when cells were 
treated with the mRyR1 inhibitor, 1 μM Dantrolene, the systolic 
Ca2+ level in cytosol was significantly elevated.
It is generally accepted that Ca2+ crosses the outer 
mitochondrial membrane via non-specific high-conductance 
voltage-dependent anion channels (VDAC) (see Shoshan-Barmatz 
et  al., 2008, for review). Specifically, it has been demonstrated 
that VDAC1 plays a major role in ER/mitochondria-Ca2+ cross-
talk (Shoshan-Barmatz et al., 2017) by forming a supra-molecular 
complex with the IP3 receptor in the SR and VDAC1  in the 
OMM, linked by a chaperone called GRP75 (Csordás et  al., 
2006), together with Mfn2 (de Brito and Scorrano, 2008). 
It is plausible that Mfn2-mediated tethering creates a 
microenvironment with highly elevated Ca2+ levels to enhance 
Ca2+ transfer via VDAC1; however, the direct experimental 
evidence of the enhanced Ca2+ channeling via VDAC1 by Mfn2 
is lacking. Several studies, however, demonstrated that VDAC1 
is highly Ca2+-permeable and modulates the accessibility of 
Ca2+ to the intermembrane space (IMS) (Gincel et  al., 2001; 
Rapizzi et  al., 2002; De Stefani et  al., 2012). The importance 
of the 18-kDa outer mitochondrial membrane transporter protein 
(TSPO) in mitochondrial Ca2+ transport and its role in heart 
failure have been recently revealed by Thai et al. (2018) ringing 
attention to the outer mitochondrial membrane proteins in 
regulation of the mitochondrial Ca2+ uptake and bioenergetics.
Interestingly, not all mitochondria within the myocyte take 
up Ca2+ into their matrix following IP3R activation to the 
same extent. Detailed analysis of mitochondrial subpopulations 
revealed that in WT cardiac myocytes IFM and PNM take 
up almost two times more Ca2+ following IP3-mediated SR 
Ca2+ release compared to the SSM regions (Figure 3). In Mfn2-
deficient myocytes, mitochondrial Ca2+ uptake following IP3R 
activation was not different between all three mitochondrial 
subpopulations. This finding is supported by several studies 
providing evidence for not only structural differences of IFM 
(Fawcett and McNutt, 1969; Shimada et  al., 1984; Lukyanenko 
et  al., 2009), PNM, and SSM but also functional differences 
between these mitochondrial populations. It has been suggested 
that IFM produce ATP primarily for contraction, PNM for 
nuclear processes, and SSM provide ATP for active transport 
processes across the sarcolemma (Müller, 1976; Palmer et  al., 
1977; Shimada et  al., 1984; Rosca and Hoppel, 2013). Since 
ET-1 has a positive inotropic effect and activates pathological 
gene transcription in the nucleus, a preferential effect of ET-1 
on IFM and PNM is in agreement with these findings.
As expected, since mitochondrial Ca2+ uptake following ET-1 
stimulation was abolished in Mfn-2 KO mice, ATP production 
was not detectable in Mfn2-deficient cardiomyocytes. Interestingly, 
the basal mitochondrial membrane potential measured with 
TMRM was not different between the two genotypes, which 
is in accordance with the results of Chen et al. (2012); however, 
ET-1 stimulation led to the increase in mitochondrial membrane 
potential (Figure 4), which contributes to the enhanced electron 
transfer chain coupling and ATP generation (Figure 5). Taken 
together, these results indicate a crucial role of physical tethering 
of SR and mitochondria by Mfn2 for adaptation of energy 
production to chronic stress. Interestingly, the effect of ISO 
on [Ca2+]m levels in the three mitochondrial subgroups was 
different from ET-1. The highest mitochondrial Ca2+ uptake 
was detected in subsarcolemmal mitochondria, which gradually 
declined in IFM and was the smallest in perinuclear mitochondria. 
Furthermore, while Mfn-2 KO had no effect on ISO-induced 
[Ca2+]m levels in SSM and IFM mitochondrial regions (Figures 
3E,F), mitochondrial Ca2+ uptake actually increased in perinuclear 
mitochondria (Figure 3G) in cardiomyocytes from Mfn2 
KO animals.
These data suggest that tethering between SR and mitochondria 
is heterogeneous within ventricular myocytes to support the 
privileged SR-mitochondrial communication between IR3 receptors 
and mRyR1. When this communication was lost in Mfn-2 KO 
mice, perinuclear mitochondria picked up significantly more 
Ca2+ upon ISO stimulation. This increase in mitochondrial Ca2+ 
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during ISO stimulation in PNM regions in Mfn-2 KO mice 
was also associated with the highest ATP levels in Mfn-2 deficient 
myocytes (see Figure 5). This difference between ET-1 and ISO 
responses in WT and Mfn-2 KO mice could explain the existent 
controversy in the field [(Filadi et  al., 2015) vs. (de Brito and 
Scorrano, 2008) and (Naon et  al., 2016)] on the role of Mfn2-
mediated tethers in SR-mitochondrial Ca2+ communication.
CONCLUSIONS
Our study demonstrates that in ventricular myocytes, basal 
ET-1 signaling is required for maintaining normal cardiac 
function and bioenergetics (Figure 6). We  have shown that 
when the physical linkage between SR and mitochondria Mfn-2 
is disrupted, the SR/mitochondrial metabolic feedback mechanism 
is severely impaired resulting in the inability of the IP3-mediated 
SR Ca2+ release to induce ATP production. These findings 
could explain the impaired cardiac function observed in aged 
mice and young mice following TAC (Goh et  al., 2016) where 
Mfn2 levels were decreased leading to an impaired metabolic 
IP3-mediated SR/mitochondrial feedback.
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